+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06787677

Safety and Effectiveness of Pulsed Radiofrequency Treatment on the Sphenopalatine Ganglion for Adults with Chronic Cluster Headache

Led by Beijing Tiantan Hospital · Updated on 2025-01-27

108

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Cluster headache is a severe condition marked by intense one-sided headaches and related nerve symptoms, affecting about 0.1% of people each year. This trial aims to evaluate the safety and effectiveness of using pulsed radiofrequency PRF treatment targeting the sphenopalatine ganglion SPG for patients suffering from chronic cluster headache. The study is randomized and controlled to provide clear evidence about this treatment approach. Participants will receive one of two treatments after a needle reaches the SPG. The experimental group will get PRF treatment for 360 seconds at a set temperature and pulse frequency. The comparison group will receive a nerve block using a mixture of medications including triamcinolone and bupivacaine. The study will monitor participants for up to one year to assess the effects of these procedures. During the study, researchers will track the frequency and intensity of headache attacks using regular assessments over 12 months. They will also collect patient feedback on improvement and satisfaction. Safety will be monitored by recording any adverse events within a year after treatment. Participation involves regular follow-up visits to evaluate outcomes and ensure ongoing safety and care.

CONDITIONS

Brief Title

SPG Pulsed Radiofrequency for Chronic Cluster Headache

Research Team

F

Fang Luo

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here